{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-037425","form_type":"8-K/A","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.511079+00:00","generated_at":"2026-05-17T21:28:45.198143+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Indivior assigns new director Kingsley to Audit & Risk and Compensation committees","bullets":["Stuart A. (Tony) Kingsley appointed non-executive director effective July 1, 2025.","He will serve on the Audit & Risk Committee and the Compensation Committee.","Appointment previously disclosed; amendment adds committee assignment details."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-037425","json":"https://secwatch.observer/filing/0001628280-25-037425.json","markdown":"https://secwatch.observer/filing/0001628280-25-037425.md","text":"https://secwatch.observer/filing/0001628280-25-037425.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/0001628280-25-037425-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162828025037425/indv-20250620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:28:45.198143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}